Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways

Journal of Clinical Investigation

Volumn 108, Issue 10, 2001, Pages 1459-1467

  Yasukawa, Hideo ^a   Hoshijima, Masahiko ^a   Gu, Yusu ^a   Nakamura, Tomoyuki ^a   Pradervand, Sylvain ^a   Hanada, Toshikatsu ^b,c   Hanakawa, Yasushi ^d   Yoshimura, Akihiko ^b   Ross Jr , John ^a   Chien, Kenneth R ^a,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; BIOMECHANICS; CELL PROTECTION; CELL SURVIVAL; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE TRANSFER; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; MECHANICAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPE; PRESSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STRESS;

EID: 0035188432     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13939     Document Type: Article

References (39)

1. Signaling pathways for cardiac hypertrophy and failure
2. Stress pathways and heart failure
3. Signaling in myocardial hypertrophy: Life after calcineurin?
4. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
5. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apotosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction
6. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy
7. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart
8. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways
9. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
10. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes
11. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart
12. Elevated circulating cardiotrophin-1 in heart failure: Relationship with parameters of left ventricular systolic dysfunction
13. A novel role for STAT3 in cardiac remodeling
14. Gp130 and the interleukin-6 family of cytokines
15. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor
16. The suppressors of cytokine signaling (SOCS) proteins: Important feedback inhibitors of cytokine action
17. Negative regulation of cytokine signaling pathways
18. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
19. Twenty proteins containing a C-terminal SOCS box form five structural classes
20. Cloning and characterization of novel CIS family genes
21. Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
22. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons
23. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo
24. CIS3/SOCS-3 suppresses erythropoietin(EPO) signaling by binding the EPO receptor and JAK2
25. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
26. SOCS3 is essential in the regulation of fetal liver erythropoiesis
27. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy
28. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
29. Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes
30. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
31. The low molecular weight GTPase Kho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase
32. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy
33. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
34. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
35. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro
36. Cardiac hypertrophy: Sorting out the circuitry
37. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
38. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles
39. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo